| 4d ago | | IMMUNOGEN, INC.: Ongoing Clinical Trials Reveal Groundbreaking Results - Resear.. |
| 06/03 | | IMMUNOGEN, INC.: First Clinical Data Presented with IMGN853, ImmunoGen, Inc.'s .. |
| 05/30 | | IMMUNOGEN, INC.: Announces Webcast of Presentations at Upcoming Investor Confer.. |
| 05/03 | | IMMUNOGEN, INC.: Announces Webcast of Presentation at Upcoming Investor Confere.. |
| 04/26 | | IMMUNOGEN, INC.: Reports Third Quarter Fiscal Year 2013 Financial Results and P.. |
| 04/23 |  | IMMUNOGEN, INC.: quaterly earnings release |
| 04/18 | | IMMUNOGEN, INC.: Announces Conference Call to Discuss its Third Quarter Fiscal .. |
| 04/11 | | IMMUNOGEN, INC.: Webcast of the ImmunoGen, Inc. Analyst and Investor Community .. |
| 04/10 | | IMMUNOGEN, INC.: Announces Preclinical Findings with its IMGN289 Product Candid.. |
| 03/12 | | IMMUNOGEN, INC.: Announces Webcast of its Analyst and Investor Community Meetin.. |
| 02/22 | DJ | FDA Approves Kadcyla, Breast-Cancer Drug From Roche, ImmunoGen |
| 02/22 | DJ | FDA Approves Breast-Cancer Drug |
| 02/22 | DJ | FDA Approves Kadcyla, Breast-Cancer Drug from Roche, ImmunoGen |
| 02/22 | | IMMUNOGEN, INC.: Announces FDA Approval of Kadcyla (Ado-Trastuzumab Emtansine; .. |
| 02/12 | | IMMUNOGEN, INC.: Attains Patient Enrollment Milestone in IMGN901 NORTH Trial |
| 02/05 | | IMMUNOGEN, INC.: Announces Webcast of Presentations at Upcoming Investor Confer.. |
| 01/25 | | IMMUNOGEN, INC.: Reports Second Quarter Fiscal Year 2013 Financial Results and .. |
| 01/22 | | IMMUNOGEN, INC.: quaterly earnings release |
| 01/18 | | IMMUNOGEN, INC.: Announces Conference Call to Discuss its Second Quarter Fiscal.. |
| 01/02 | | IMMUNOGEN, INC.: Announces Webcast of Presentation at the 31st Annual J.P. Morg.. |
| 2012 | | IMMUNOGEN, INC.: Amgen Takes Third License for Rights to Use ImmunoGen's TAP Te.. |
| 2012 | | IMMUNOGEN, INC.: Announces IMGN901 Clinical Data Presented at ASH |
| 2012 | | IMMUNOGEN, INC.: Announces Webcast of Presentation at the Oppenheimer 23rd Annu.. |
| 2012 | | IMMUNOGEN, INC.: Announces Clinical Data Presentations at the 54th ASH Annual M.. |
| 2012 | | IMMUNOGEN, INC.: Appoints Dr. Charles Morris as Chief Development Officer |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | FDA Gives Priority Review to ImmunoGen, Roche Breast Cancer Drug |
| 2012 | | IMMUNOGEN, INC.: Announces FDA Has Granted Priority Review Status to the Trastu.. |
| 2012 | | IMMUNOGEN, INC.: Announces Webcast of Presentations at Upcoming Investor Confer.. |
| 2012 | | IMMUNOGEN, INC.: Reports First Quarter Fiscal Year 2013 Financial Results and P.. |
| 2012 | | IMMUNOGEN, INC.: quaterly earnings release |
| 2012 | | IMMUNOGEN, INC.: Announces Conference Call to Discuss its First Quarter Fiscal .. |
| 2012 | | IMMUNOGEN, INC.: Announces Overall Survival Data Reported for Trastuzumab Emtan.. |
| 2012 | | IMMUNOGEN, INC.: Announces Presentation of New IMGN901 Clinical Data |
| 2012 | | IMMUNOGEN, INC.: Announces Webcast of Presentations at Upcoming Investor Confer.. |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | ImmunoGen Breast Cancer Drug Shows Positive Results; Shares Up |
| 2012 | | IMMUNOGEN, INC.: Announces Trastuzumab Emtansine (T-DM1) Significantly Improved.. |
| 2012 | | IMMUNOGEN, INC.: Reports Fourth Quarter and Fiscal Year 2012 Financial Results .. |
| 2012 | | IMMUNOGEN, INC.: Announces Conference Call to Discuss its Fourth Quarter and Fi.. |
| 2012 | | IMMUNOGEN, INC.: Prices Public Offering of Common Stock |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | | IMMUNOGEN, INC.: Announces Proposed Public Offering of Common Stock |
| 2012 | | IMMUNOGEN, INC.: Initiates Phase I Trial of IMGN853 in Ovarian Cancer and Other.. |
| 2012 | | IMMUNOGEN, INC.: Announces Presentation of New Clinical Data for SAR3419 |
| 2012 | | IMMUNOGEN, INC.: Announces Development of Trastuzumab Emtansine for Early Stage.. |
| 2012 | | IMMUNOGEN, INC.: Announces Results from Trastuzumab Emtansine (T-DM1) EMILIA Ph.. |
| 2012 | | IMMUNOGEN, INC.: Announces Presentations at 2012 ASCO Annual Meeting on Product.. |
| 2012 | | IMMUNOGEN, INC.: Announces Presentations at 2012 ASCO Annual Meeting on Product.. |
| 2012 | | IMMUNOGEN, INC.: Announces Webcast of Presentations at Upcoming Investor Confer.. |
| 2012 | | IMMUNOGEN, INC.: Reports Third Quarter Fiscal Year 2012 Financial Results and P.. |
| 2012 | | IMMUNOGEN, INC.: Announces Conference Call to Discuss its Third Quarter Fiscal .. |
| 2012 | | IMMUNOGEN, INC.: Announces the IND Is Now Active for Its Folate-Receptor Target.. |
| 2012 | | IMMUNOGEN, INC.: Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its Nov.. |
| 2012 | DJ | Roche Breast Cancer Drug Shows Late-Stage Success |
| 2012 | DJ | New Roche Breast Cancer Drug Shows Late Stage Trial Success |
| 2012 | | IMMUNOGEN, INC.: Announces Conference Call at 8:00 am ET March 30, 2012 to Disc.. |
| 2012 | | IMMUNOGEN, INC.: Announces Conference Call at 8:00 am ET March 30, 2012 to Disc.. |
| 2012 | | IMMUNOGEN, INC.: Announces Initiation of Phase II Evaluation of Its IMGN901 Pro.. |
| 2012 | | IMMUNOGEN, INC.: Announces Positive Results in Trastuzumab Emtansine (T-DM1) EM.. |
| 2012 | | IMMUNOGEN, INC.: Announces Webcast of Presentation at the Cowen 32nd Annual Hea.. |
| 2012 | | IMMUNOGEN, INC.: Announces Webcast of Presentations at Upcoming Investor Confer.. |
| 2012 | | IMMUNOGEN, INC.: Announces Addition of Kristine Peterson and Dean Mitchell to I.. |
| 2012 | | IMMUNOGEN, INC.: Announces Conference Call to Discuss its Second Quarter Fiscal.. |
| 2011 | | IMMUNOGEN, INC.: Announces Antibody-Drug Conjugate Collaboration With Lilly |
| 2011 | | IMMUNOGEN, INC.: Earns Milestone Payment From Amgen With IND Achievement for Se.. |
| 2011 | | IMMUNOGEN, INC.: Earns Milestone From Amgen With IND Achievement |
| 2011 | | IMMUNOGEN, INC.: Announces Webcast of Presentations at Upcoming Investor Confer.. |
| 2011 | | IMMUNOGEN, INC.: Reports First Quarter Fiscal Year 2012 Financial Results and P.. |
| 2011 | | IMMUNGN: ImmunoGen, Inc. Earns Milestone With Start of SAR3419 Phase II Testing |
| 2011 | | IMMUNGN: ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter.. |
| 2011 | | IMMUNGN: ImmunoGen, Inc. Announces Webcast of Presentation at the 18th Annual N.. |
| 2011 | | IMMUNGN: T-DM1 Significantly Improved Progression-Free Survival Compared to Sta.. |
| 2011 | | IMMUNGN: ImmunoGen, Inc. Announces Submission of IND for Wholly Owned Product C.. |
